QVP

Sars-Cov-2 Serology Test

Product code
QVP
Device name
Sars-Cov-2 Serology Test
Device class
Class 2
21 CFR
21 CFR 866.3983
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
5 (all years; only the last 3 years are listed here)

FDA classification definition

A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-04-13.

NumberDecision dateApplicantDevice nameSummary
K2522802026-04-13Roche DiagnosticsElecsys Anti-SARS-CoV-2 SPDF
K2538392025-12-17Roche DiagnosticsElecsys Anti-SARS-CoV-2PDF
K2507682025-06-10Roche DiagnosticsElecsys Anti-SARS-CoV-2PDF

3 summaries are archived here for direct download.

Official FDA classification page: QVP
Classification and pathway per current FDA publications. Data from openFDA (CC0).